Global Nanomedicines Market Size, Status and Forecast 2020-2026

  • receipt Report ID : 29639
  • calendar_today Published On: Apr, 2020
  • file_copy Pages: 91
  • list Pharmaceuticals and Healthcare

Nanotechnology refers to the engineering of functional systems at the molecular scale. It includes construction of items from the bottom up, using modern techniques and tools to make complete, high-performance products. Nanomedicines refer to medications that are based on the application of nanotechnology in the medical field. They include monitoring, construction, repair, and control of human biological systems at the molecular level, using nanodevices and nanostructures.

Factors such as aging populations, increasing prevalence of disorders that could be treated better with nanomedicines, and growing awareness about the availability of alternative treatment using nanomedicines are driving the global nanomedicines market.

North America dominates the global market for nanomedicines due to its large population of senior citizens, leading to an increased demand for improved and efficient medications, and technological advancements in the region. Europe, followed by Asia, is expected to experience high growth rate in the next few years in global nanomedicines market. China and India are expected to be the fastest-growing nanomedicines markets in Asia. Some of the key drivers for the nanomedicines market in emerging countries are the large pool of patients, rising government funding, and increasing research and development in the field of medicine.

In 2020, the global Nanomedicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2020-2026.

This report focuses on the global Nanomedicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanomedicines development in United States, Europe and China.

The key players covered in this study

Abbott

GE Healthcare

Johnson & Johnson

Merck

Pfizer

CombiMatrix

Celgene

Mallinckrodt

Sigma-Tau Pharmaceuticals

Teva Pharmaceutical

Nanosphere

UCB SA

Market segment by Type, the product can be split into

Nanoparticles

Nanoshells

Nanotubes

Nanodevices

Others

Market segment by Application, split into

Hospitals

Clinics

Research Institute

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Nanomedicines status, future forecast, growth opportunity, key market and key players.

To present the Nanomedicines development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Nanomedicines are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Nanomedicines Market Size Growth Rate by Type (2015-2026)

1.4.2 Nanoparticles

1.4.3 Nanoshells

1.4.4 Nanotubes

1.4.5 Nanodevices

1.4.6 Others

1.5 Market by Application

1.5.1 Global Nanomedicines Market Share by Application (2015-2026)

1.5.2 Hospitals

1.5.3 Clinics

1.5.4 Research Institute

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Nanomedicines Market Size

2.2 Nanomedicines Growth Trends by Regions

2.2.1 Nanomedicines Market Size by Regions (2015-2026)

2.2.2 Nanomedicines Market Share by Regions (2015-2020)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Nanomedicines Market Size by Manufacturers

3.1.1 Global Nanomedicines Revenue by Manufacturers (2015-2020)

3.1.2 Global Nanomedicines Revenue Market Share by Manufacturers (2015-2020)

3.1.3 Global Nanomedicines Market Concentration Ratio (CR5 and HHI)

3.2 Nanomedicines Key Players Head office and Area Served

3.3 Key Players Nanomedicines Product/Solution/Service

3.4 Date of Enter into Nanomedicines Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Nanomedicines Market Size by Type (2015-2020)

4.2 Global Nanomedicines Market Size by Application (2015-2020)

5 United States

5.1 United States Nanomedicines Market Size (2015-2020)

5.2 Nanomedicines Key Players in United States

5.3 United States Nanomedicines Market Size by Type

5.4 United States Nanomedicines Market Size by Application

6 Europe

6.1 Europe Nanomedicines Market Size (2015-2020)

6.2 Nanomedicines Key Players in Europe

6.3 Europe Nanomedicines Market Size by Type

6.4 Europe Nanomedicines Market Size by Application

7 China

7.1 China Nanomedicines Market Size (2015-2020)

7.2 Nanomedicines Key Players in China

7.3 China Nanomedicines Market Size by Type

7.4 China Nanomedicines Market Size by Application

8 Japan

8.1 Japan Nanomedicines Market Size (2015-2020)

8.2 Nanomedicines Key Players in Japan

8.3 Japan Nanomedicines Market Size by Type

8.4 Japan Nanomedicines Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Nanomedicines Market Size (2015-2020)

9.2 Nanomedicines Key Players in Southeast Asia

9.3 Southeast Asia Nanomedicines Market Size by Type

9.4 Southeast Asia Nanomedicines Market Size by Application

10 India

10.1 India Nanomedicines Market Size (2015-2020)

10.2 Nanomedicines Key Players in India

10.3 India Nanomedicines Market Size by Type

10.4 India Nanomedicines Market Size by Application

11 Central & South America

11.1 Central & South America Nanomedicines Market Size (2015-2020)

11.2 Nanomedicines Key Players in Central & South America

11.3 Central & South America Nanomedicines Market Size by Type

11.4 Central & South America Nanomedicines Market Size by Application

12 International Players Profiles

12.1 Abbott

12.1.1 Abbott Company Details

12.1.2 Company Description and Business Overview

12.1.3 Nanomedicines Introduction

12.1.4 Abbott Revenue in Nanomedicines Business (2015-2020)

12.1.5 Abbott Recent Development

12.2 GE Healthcare

12.2.1 GE Healthcare Company Details

12.2.2 Company Description and Business Overview

12.2.3 Nanomedicines Introduction

12.2.4 GE Healthcare Revenue in Nanomedicines Business (2015-2020)

12.2.5 GE Healthcare Recent Development

12.3 Johnson & Johnson

12.3.1 Johnson & Johnson Company Details

12.3.2 Company Description and Business Overview

12.3.3 Nanomedicines Introduction

12.3.4 Johnson & Johnson Revenue in Nanomedicines Business (2015-2020)

12.3.5 Johnson & Johnson Recent Development

12.4 Merck

12.4.1 Merck Company Details

12.4.2 Company Description and Business Overview

12.4.3 Nanomedicines Introduction

12.4.4 Merck Revenue in Nanomedicines Business (2015-2020)

12.4.5 Merck Recent Development

12.5 Pfizer

12.5.1 Pfizer Company Details

12.5.2 Company Description and Business Overview

12.5.3 Nanomedicines Introduction

12.5.4 Pfizer Revenue in Nanomedicines Business (2015-2020)

12.5.5 Pfizer Recent Development

12.6 CombiMatrix

12.6.1 CombiMatrix Company Details

12.6.2 Company Description and Business Overview

12.6.3 Nanomedicines Introduction

12.6.4 CombiMatrix Revenue in Nanomedicines Business (2015-2020)

12.6.5 CombiMatrix Recent Development

12.7 Celgene

12.7.1 Celgene Company Details

12.7.2 Company Description and Business Overview

12.7.3 Nanomedicines Introduction

12.7.4 Celgene Revenue in Nanomedicines Business (2015-2020)

12.7.5 Celgene Recent Development

12.8 Mallinckrodt

12.8.1 Mallinckrodt Company Details

12.8.2 Company Description and Business Overview

12.8.3 Nanomedicines Introduction

12.8.4 Mallinckrodt Revenue in Nanomedicines Business (2015-2020)

12.8.5 Mallinckrodt Recent Development

12.9 Sigma-Tau Pharmaceuticals

12.9.1 Sigma-Tau Pharmaceuticals Company Details

12.9.2 Company Description and Business Overview

12.9.3 Nanomedicines Introduction

12.9.4 Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2015-2020)

12.9.5 Sigma-Tau Pharmaceuticals Recent Development

12.10 Teva Pharmaceutical

12.10.1 Teva Pharmaceutical Company Details

12.10.2 Company Description and Business Overview

12.10.3 Nanomedicines Introduction

12.10.4 Teva Pharmaceutical Revenue in Nanomedicines Business (2015-2020)

12.10.5 Teva Pharmaceutical Recent Development

12.11 Nanosphere

12.12 UCB SA

13 Market Forecast 2020-2026

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2020-2026)

13.10 Market Size Forecast by Application (2020-2026)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Nanomedicines Key Market Segments

Table Key Players Nanomedicines Covered

Table Global Nanomedicines Market Size Growth Rate by Type 2015-2026 (Million US

Please fill the form below, to recieve the report sample


+1